John Del Giorno
 |
Learn more about corporations VOTING to rewrite our laws. |
John Del Giorno is the Vice President of State Government Affairs at GlaxoSmithKline.[1] GlaxoSmithKline (GSK) is an international pharmaceutical giant headquartered in Britain. GSK traces its heritage back to a London pharmacy established in 1715. Various entities, including Burroughs Wellcome & Company, Smith-Kline & French Laboratories and Glaxo Laboratories merged to form GSK. [2] GSK is one of the top five drug firms in the world.
Contents
Ties to the American Legislative Exchange Council
Del Giorno also represents GlaxoSmithKline on the Private Enterprise Board of the American Legislative Exchange Council (ALEC) as of 2011.[3] He has been a member of the Private Enterprise Board since at least early 1999, when he was listed on ALEC's 1998 Form 990.[4]
| About ALEC |
|---|
ALEC is a corporate bill mill. It is not just a lobby or a front group; it is much more powerful than that. Through ALEC, corporations hand state legislators their wishlists to benefit their bottom line. Corporations fund almost all of ALEC's operations. They pay for a seat on ALEC task forces where corporate lobbyists and special interest reps vote with elected officials to approve “model” bills. Learn more at the Center for Media and Democracy's ALECexposed.org, and check out breaking news on our PRWatch.org site.
|
Resources
Related SourceWatch articles
References
- ↑ LinkedIn, "John Del Giorno," business profile, accessed July 7, 2011
- ↑ Our History, GlaxoSmithKline, accessed February 2009
- ↑ American Legislative Exchange Council, Private Enterprise Board, organizational website, accessed July 8, 2011
- ↑ American Legislative Exchange Council, 1998 Form 990, form filed with the IRS and available via Guidestar.org, May 14, 1999
External articles
| This article is a stub. You can help by expanding it. |
